Terumo to Make Full Entry into Market for Catheter-based Treatment for Cerebral Vascular Disease.
MicroVention specializes in the production of hydrogel-coated and bare platinum coils for the treatment of cerebral vascular aneurysms, and has about a 15% share of the global market.
With the US company under its arm, Terumo aims to make a full entry into the field of catheter-based treatment for cerebral vascular diseases.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Mar 3, 2006|
|Previous Article:||ANA to Introduce "Euphony ANA Audio" Technology for In-Flight Entertainment.|
|Next Article:||Info Plant Survey: When - and How Often - Do Japanese Consumers Frequent Department Stores?|
|Goodman to Exclusively Distribute Embolic Coils from Micrus Endovascular.|